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Objective:  To  estimate  the  additional  cost  attributable  to nosocomial  infection  (NI)  in  a pediatric  intensive
care  unit  (PICU)  and  related  factors.
Methods:  A  prospective  cohort  study  was  conducted  in all children  admitted  to the  PICU  of  a  tertiary-
care  pediatric  hospital  between  2008  and  2009.  Descriptive  and  bivariate  analyses  were  conducted  of
total direct  costs  due  to PICU stay  and  medical  procedures  in patients  with  and  without  NI.  A log-linear
regression  model  was  performed  to  determine  the  factors  associated  with  higher  total  cost.
Results:  A  total  of  443  patients  were  studied  and  the  prevalence  of  NI was  11.3%.  The  difference  in the
median  total  cost  was  D 30,791.4  per  patient  between  groups  with  and  without  NI.  The median  cost  of
PICU  length  of  stay  in  patients  with  NI was  almost  eight  times  higher  than  the  median  cost  of  patients
without  NI. In patients  with  NI,  the  highest  costs  related  to medical  procedures  were  associated  with
antibiotics,  enteral  and  parenteral  feeding,  and  imaging  tests.  In the  multivariate  model,  the  factors  asso-
ciated  with  higher  cost  were  infection,  the performance  of cardiovascular  surgery,  urgent admission,  a
higher  pediatric  risk  mortality  score,  and  the  presence  of  immunosuppression.  By  contrast,  older  children
and those  with surgical  admission  generated  lower  cost.
Conclusions:  NI  was  associated  with  an increase  in  total  cost,  which  implies  that  the  prevention  of these
infections  through  speciﬁc  interventions  could  be cost-effective  and  would  help  to  increase  the  safety  of
healthcare  systems.
© 2014  SESPAS.  Published  by  Elsevier  España,  S.L.U.  All  rights  reserved.
Coste  asociado  a  la  infección  nosocomial  en  una  unidad  de  cuidados  intensivos
pediátricos
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Objetivo:  El  objetivo  del estudio  es estimar  el  coste  adicional  atribuible  a la  infección  nosocomial  (IN)  en
una  Unidad  Pediátrica  de  Cuidados  Intensivos  (UCIP)  y sus  factores  asociados.
Método:  estudio  de  cohortes  prospectivo  de todos  los  pacientes  ingresados  en  una  UCIP  de  tercer  nivel
entre  2008  y  2009.  Se realizó  un  análisis  descriptivo  y bivariante  del  coste  total  asociados  a estancia  en
UCIP  y procedimientos  en  pacientes  con  y  sin IN. Mediante  regresión  lineal  múltiple,  se  estimaron  los
factores  asociados  al incremento  del  coste  total.egresión
Resultados: se  estudiaron  443 pacientes,  la  incidencia  de  IN fue  11,3%.  La  diferencia  de  las  medianas  en  el
coste  total  fue  de  30.791,4D  por  paciente  entre  los  grupos  con  y sin  IN.  El  coste  mediano  de  la  estancia  de
pacientes  con  IN  fue  casi  ocho  veces  mayor  que el coste  mediano  de  los  pacientes  sin  IN.  En  pacientes  con
IN, el  coste  asociado  a procedimientos  más  elevado  fue el de  antibióticos,  nutrición  enteral  y parenteral
y  pruebas  de  imagen.  En  el  modelo  multivariante  los  factores  asociados  con  un  mayor  coste  fueron:
presencia  de  infección  nosocomial,  cirugía  cardiovascular,  tipo  ingreso  urgente,  mayor  índice  pronóstico
de  mortalidad  al ingreso  y  la presencia  de inmunosupresión.  Por  el  contrario,  los  de  mayor  edad  y aquellos
ingresados  por  cirugía  presentaron  un  menor  coste.
∗ Corresponding author. Servicio de Medicina Preventiva y Salud Pública, Hospital Universitario Virgen del Rocío, Avda. Manuel Siurot s/n 41013, Sevilla, Espan˜a.
el.:  +34 955013287; fax: +34 955013285.
E-mail address: aurea.morillo@gmail.com (Á. Morillo-García).
http://dx.doi.org/10.1016/j.gaceta.2015.02.008
213-9111/© 2014 SESPAS. Published by Elsevier España, S.L.U. All rights reserved.
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Conclusiones:  La  IN está  asociada  al  incremento  del coste  total, lo que  implica  que  la  prevención  de  estas
infecciones  mediante  intervenciones  especíﬁcas  podría  resultar  costo-efectiva,  redundando  en  sistemas
de  salud  más  seguros.
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In Pediatric Intensive Care Units (PICU), the prevalence of noso-
omial infection (NI) is variable, ranging from 10 to 33%1,2, and
ncidence rates from 5.9 to 15 per 1,000 patient-days3,4. This is
xplained by the greater complexity of these patients affected by a
ariety of medical and surgical pathologies1.
NI is also considered one of the most costly problems for hos-
itals. The most important direct NI-associated cost comes from
he increase in the excess of length of stay (LOS)5. Therefore, most
eports focus on NI-related costs due to LOS, as it is quite easy to
ranslate such costs to currency value, applying the local cost per
ospitalization day6. Further studies also have taken into account
he costs of diagnostic and medical procedures, derived from or
ue to the infection, as the most accurate way to calculate the
I-attributable cost7–10.
The study of NI-associated cost has evolved in time with the
ntroduction of new cost estimation methods11–13. The most com-
on  comparative method used to analyse the cost of NI, is the
rospective or retrospective observational study of the hospital
nvironment14.
Few studies have assessed the impact of NI on total costs in
ICU15, some of them have analysed the cost attributable to any
ype of NI in PICU7,11,12,16, others have focused only on nosocomial
rimary bloodstream infection8,9. The average cost attributable to
I described in literature ranges between D 1,51017-53,0859 per
atient.
The Spanish Public Healthcare System is a tax-ﬁnanced system
hat offers universal coverage, which is different from privately-
unded healthcare systems, where most of the published reports
n NI-related cost have been performed5,7. The lack of previous
panish reports about NI costs in PICU and the actual economical
risis in this country, justiﬁes the present paper. The aim of the
tudy is to estimate the cost attributable to nosocomial infection in
 pediatric intensive care unit and its related factors.
ATERIAL AND METHODS
tudy Design
Prospective cohort study between September 2008 and July
009. The study was carried out in a 16-bed multidisciplinary
ICU of a tertiary-care university hospital of the Andalusian Pub-
ic Health System. This Unit is a regional referent institution for
ighly complex procedures, and offers assistance to patients older
han 28 days of age and also to neonates during the cardiovascu-
ar surgery postoperative period. All patients admitted in the PICU
or less than 24 hours were excluded (a total of 426 patients were
xcluded). Nine patients remained hospitalized at the end of the
tudy.
ariablesThe dependent variable was total cost (only took into account
he costs incurred in the PICU), which included the sum of
he following cost items: PICU LOS, invasive mechanical ven-
ilation, imaging and microbiological tests, enteral and totalSPAS.  Publicado  por  Elsevier  España,  S.L.U.  Todos  los derechos  reservados.
parenteral nutrition, antibiotherapy, consumables (central line, uri-
nary catheter) and structure costs.
The following independent variables were collected: a) Sociode-
mographic and admission variables: Age, sex, type and cause of
PICU admission and cause of discharge; b) Clinical variables: Pres-
ence of NI, classiﬁed according the deﬁnitions of the Centers of
Disease Control and Prevention18; c) Risk factors for NI1: factors
related to patient’s intrinsic characteristics and factors related to
surgery and other procedures made during PICU stay.
Sources of information
The consumption of different resources (LOS, special feeding
formulas and parenteral nutrition, days of mechanical ventilation,
imaging and microbiological tests, antibiotherapy and consuma-
bles) was  obtained from medical records and direct observation,
all of which were validated with PICU pediatrician.
The cost of imaging procedures was  obtained from the Andalu-
sian Ofﬁcial Bulletin Board19. Cost of consumables, those related
to PICU stay, nutrition, mechanical ventilation and antibiother-
apy were obtained from the hospital accounting system. Costs of
microbiological tests were obtained from an external reference
laboratory20. All costs were updated to the present-day currency
in Spain, the Euro (2009).
Costs estimation
1) The estimation of PICU LOS (it includes the costs of PICU staff,
consumable goods, catering, instruments and tools, inversions,
cleaning, ofﬁce material, conservation and repair, professional ser-
vices and supplies for the PICU) was calculated according to the
method suggested by Brazzi et al.21 2) The average cost per day of
enteral feeding and total parenteral nutrition was  calculated and
attributed to each patient. 3) The average cost of invasive mechan-
ical ventilation was  calculated per patient according to the cost of
acquisition, usage and lifespan. 4) For the estimation of the struc-
ture costs we  used the method suggested by Mason et al.22, which
means add 25% to the direct cost. All of them were validated with
PICU pediatrician.
Data were collected from the clinical records by trained person-
nel in epidemiological surveillance and tabulated in a spreadsheet
which was speciﬁcally designed for this study. The data collection
model applied included consumable goods used per patient. These
data were classiﬁed according to whether they were attributable
or not to NI, depending on the most prevalent NI types. The crite-
ria considered to attribute procedures to NI are shown in Table 1.
Finally, the project was  approved by the hospital Ethics Committee.
Statistical Analysis
NI deﬁnition, and infection rates (with 95% conﬁdence intervals)
proposed by the National Nosocomial Infections Surveillance Sys-
tem were estimated23. The chi-squared test was used to compare
proportions (NI presence or absence).NI costs were calculated from the hospital perspective. As a
result, we only considered direct tangible costs of PICU for global
NI (includes bloodstream infection, pneumonia, urinary tract infec-
tion and surgical site infection). In order to calculate average cost,
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Table 1
Criteria used to attribute medical procedures-related costs to nosocomial infection
(NI).
Type of medical
procedure
Description
Use of central venous
catheter
Catheter replacement due to suspected
bloodstream infection will be attributed to NI,
whenever the criteria set by the Centers for
Disease Control and Prevention (CDC) are met.
Invasive Mechanical
Ventilation
The onset and/or extension of invasive
mechanical ventilation in case of clinical
worsening of a patient with lower respiratory
tract infection or as a result of worsening of
other NI considered within the context of cost
analysis.
Urinary catheter The cost of the urinary catheter or its
replacement will be attributed to NI whenever
urinary tract infection acquired during the
urinary catheterization period is conﬁrmed.
Microbiological,
Imaging and
antibiotherapy tests
Any microbiological cultures, Imaging tests and
antibiotic therapy required for the diagnosis
and treatment of NI and which are not
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Table 3
Bivariant Analysis between nosocomial infection and sociodemographic and admis-
sion variables.
Without Nosocomial
Infection N (%)
With Nosocomial
Infection N (%)
Sexb
Boy 228 (90.5%) 24 (9.5%)
Girl  165 (86.4%) 26 (13.6%)
Procedenceb
Other hospital 44 (88%) 6 (12%)
Home 48 (92.3%) 4 (7.7%)
Operating room 119 (93.7%) 8 (6.3%)
Other service 182 (85%) 32 (15%)
Presence of malformationb
No 195 (90.3%) 21 (9.7%)
Yes  198 (87.2%) 29 (12.8%)
Cause of PICU admission b
Medical 159 (88.3%) 21 (11.7%)
Surgical 208 (88.1%) 28 (11.9%)
Trauma 12 (100%) 0 (0%)
Transplant 10 (90.9%) 1 (9.1%)
Others 4 (100%) 0 (0%)
Age groupsa
0-2 months 44 (74,6%) 15 (25.4%)
3  months - 1 years 109 (85.8%) 18 (14.2%)
2-5  years 126 (95.5%) 6 (4.5%)
6-12 years 74 (90.2%) 8 (9.8%)
Over 12 years 40 (93%) 3 (7%)
a p < 0.001
b
T
I
*
pincluded in the medical protocol required by
the  cause of admission will be attributed to NI.
he procedures required per patient, which were attributable to NI,
ere considered. To check whether these procedures were justiﬁed
r not, patients’ clinical record and interviewed with pediatrician
ere reviewed.
First of all, a descriptive analysis was performed through mean,
edian, standard deviation and range. Subsequently, univariate
nalysis established differences between total cost and indepen-
ent variables (Mann-Whitney U and Kruskal-Wallis tests for
ndependent categorical variables, and linear regression analysis
or independent continuous variables).
A multivariate linear regression was performed to determine
he NI cost adjusted by different variables. The variable cost was
og transformed, because it was not normally distributed. Clini-
ally relevant variables, those which a priori would be expected to
redict costs and those that were shown to be associated at a statis-
ically signiﬁcant level, were selected for inclusion in the model. The
on-collinearity, homogeneity of variance of the variables and the
omoscedasticity of the model as well as data ﬁtting using Cook’s
istance, the relationship between outliers and standard points and
he normal distribution of outliers, were checked. The analysis was
arried out using the statistical software package SPSS.v19.
esults
The number of patients enrolled in the study was 443 (57% were
oys), with a median age of 1.5 years (percentile 25: 5.3 months-
ercentile 75: 6.2 years). The cause of admission was  surgery in
8.5% of patients, being cardiovascular surgery the most common
ntervention (46.33%). Global mortality in the Unit was  6.3%. The
ost frequent procedures were: use of antibiotics, central venous
atheterization and invasive mechanical ventilation (85%, 64% and
able 2
ncidence of nosocomial infection sites.
Nosocomial Infection Site Number of episodes Frequ
Bloodstream infection 35 42.7 
Pneumonia 23 28.0 
Surgical site infection 11 13.4 
Urinary tract infection 7 8.5 
Other  infection 6 7.3 
 No. Nosocomial infections (NI)/total number of infections*100 †No. NI/total number of p
neumonias per 1,000 days with mechanical ventilation; No. surgical site infection/total p > 0.05N: number of patients.
55%, respectively). Fifty patients suffered, at least, one episode
of NI, which means a prevalence of patients with NI of 11.3%.
The total number of NIs was 82 in 443 patients (14.71%). Table 2
shows the number of infections according to site and infection rates
which ranged between 7.9% (bloodstream infections incidence) to
1.4% (other infections). 60.6% of the infected patients had a single
episode of infection, 18.2% had two infections, and 16.7% had three
infections. Two  patients had up to 4 infections during admission to
the Unit.
Non signiﬁcant differences were found between patients who
had NI and those who  didn’t according to gender, patient origin,
presence of malformation and reason for admission. On the con-
trary, those with a younger age had a higher risk of NI in comparison
to those who were older (Table 3).
Table 4 shows the relationship between the total cost and
independent variables for the patients admitted in the PICU. It
highlights the higher median cost in children with less than 2
months of age (D 6,903.30) and the difference in median cost
between bloodstream infection and pneumonia (D 37,356.68 and
D 34,912.96, respectively). Furthermore, the cost increase was pro-
portional to the number of NI diagnosed, with a difference in
median cost between having a single infection and 3 or 4 infections
of D 38,202.57.
ency* (%) Incidence Rate†
(%)
Incidence Density
Rate‡
7.9 14.43
5.2 15.76
2.5 4.25
1.6 -
1.4 -
atients*100; ‡No. bloodstream infections per 1,000 days central line catheter; No.
of surgical interventions *100.
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Table  4
Cost analysis of variables related to admission, patient’s intrinsic characteristics, and
variables related or due to procedures during pediatric intensive care unit (PICU)
stay.
Total Cost D
Average (Median)
p
Age groups
0-2 months 12,391.54 (6,903.30)
3  months - 1 years 10,028.14 (4,047.99)
2-5 years 6,626.95 (3,047.07)
6-12 years 5,936.10 (3,064.88)
Over 12 years 6,112.18 (3,092.41) <0.001b
Cause of PICU admission
Medical 10,831.99 (4,234.83)
Surgical 6,466.42 (3,079.48)
Trauma 2,566.42 (2,087.45)
Transplant 8,646.17 (6,548.23)
Others 6,819.02 (4,862.94) <0.001b
Type of admission
Elective 6,175.98 (3,061.63)
Emergency 10,291.44 (4,215.44) <0.001a
PRISM index
0-10 5,823.08 (3,137.58)
>10 14,416.39 (8,040.86) <0.001a
Immunosuppression
No 7,782.94 (3,179.44)
Yes 12,096.62 (6,174.37) <0.001a
Previous respiratory disease
No 7,018.44 (3,378.61)
Yes 27,812.31 (4,176.73) 0.026a
Infection at admission in PICU
No 6,866.32 (3,127.06)
Yes 11,759.96 (4,501.40) <0.001a
Cause of discharge
Healing 6,946.21 (3,203.70)
Exitus 21,681.17 (6,626.98)
Unknownc 22,420.13 (11,438.87) <0.001b
Surgery during admission
No 8,091.67 (4,048.02)
Yes 8,245.86 (3,183.97) 0.106a
Cardiovascular surgery
No 7,122.94 (3,059.62)
Yes 11,069.21 (5,157.50) <0.001a
Mechanical ventilation
No 3,559.82 (2,291.40)
Yes 11,969.72 (5,100.19) <0.001a
Total parenteral feeding
No 3,214.45 (3,430.33)
Yes 13,714.52 (9,089.37) 0.03a
Immunosuppressive therapy
No 5,908.44 (2,724.87)
Yes 10,506.52 (4,468.25) <0.001a
Use of antibiotherapy
No 3,571.58 (2,485.69)
Yes 9,000.77 (4,004.44) 0.012a
No. of nosocomial infections
None 4,657.19 (3,084.24)
One 19,041.84 (15,085.93)
Two 42,683.96 (35,019.31)
Three-four 63,213.73 (53,288.50) <0.001b
Bloodstream infection
No 5,830.76 (3,162.45)
Yes 43,187.44 (28,012.01) <0.001a
Pneumonia
No 6,458.08 (3,218.90)
Yes 41,371.04 (31,827.37) <0.001a
a Mann Whitney U test (2 categories)
b Kruskal-Wallis test (> 2 categories).
c Patients who  remained in the PICU after the study period. PICU: Pediatric Inten-
sive  Care Unit; PRISM: Pediatric Risk of Mortality
Table 5
Cost in Euros (D ) of children admitted in the Pediatric Intensive Unit (PICU) per
patient with and without nosocomial infection.
Without Infection
Average (median)
With Infection
Average (median)
PICU-stay costa 3601.21 (2386.64) 27875.97 (18695.35)
Mechanical ventilation
cost a
4.27 (0) 41.25 (34.09)
Imaging test costb 63.67 (27.69) 143.98 (101.53)
Feeding costa,b 15.34 (5.80) 20.85 (116.18)
Antibiotherapy costa 20.85 (0.93) 140.68 (33.40)
Microbiological test
cost a
83.25 (49.58) 240.49 (135.54)
Central venous
catheter related cost
29.40 (39.16) 70.50 (58.75)
Arterial catheter
related cost
2.70 (0) 5.55 (8.41)
Direct costa 3773.26 (2479.76) 28406.39 (19238.12)
Total cost a, 4716.58 (3099.70) 35507.99 (24047.64)
PICU: Pediatric Intensive Care Unit
a p < 0.001
b p < 0.005; ‡Parenteral feeding or speciﬁc infant formulas provided by the Phar-
macy Service; §Total cost= direct cost plus 25%21
Table 5 shows the differences between infection and non-
infection regarding cost. It is worth noting that about 70% of the
total cost was due to LOS expenses. In this sense, median LOS
of patients with NI was  24 days versus 3 days for those without
NI (p < 0.001). The difference in the median cost of LOS in NI-
patients, was  statistically different comparing it to those without
NI (D 18,695.35 and D 2,386.64, respectively). Regarding the total
cost of the patients with NI included, a difference in median cost
of D 20,947.94 (D 30,791.41 average cost) was observed between
patients with and without NI (p < 0.001).
The multivariate analysis shows that those with bloodstream
infections (p < 0.001) and pneumonia (p= 0.008) have a greater cost
than those without NI. It is worth noting that a higher cost in PICU
was associated with cardiovascular surgery (p < 0.001), urgent type
of admission (p= 0.004), higher Pediatric Risk of Mortality index
(p < 0.001) and the presence of inmunosuppression (p < 0.001). By
contrast, older children and surgical type of admission (p= 0.009)
presented a lower cost (Table 6).
Discussion
The analysis of NI-related costs started in countries with
privately-funded health care systems, followed by others with a
hybrid system of private and public insurance, like Spain10,24–26.
In these studies, the type of patients included and the healthcare
systems where they were performed were very different, which
hinders any possible comparison. However, all of them report a
remarkable cost associated to NI7.
In the present study, estimated costs have been based upon pro-
longed PICU LOS and variable costs of different medical procedures,
the latter being a direct attribution resulting from the NI presence,
which is a better estimation of attributable costs. In this sense, Pit-
toni and Scatto27 remark the importance of taking into account
direct variable costs to understand the real costs generated from a
patient admitted in the intensive care unit, including non complex
medical procedures as they may  affect the result of cost analysis in
an accumulative way.
The authors have performed a multivariate analysis using mul-
tiple linear regression models in order to assess factors associated
with the total cost, as it is difﬁcult to choose the matching factors
between cases and controls without committing a selection bias.
This follows the current trend in NI-related cost analysis (from 1990
to 1999, 14.3% of the studies performed multiple linear regression
and from 2000-2006, 34.5% did so28).
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Table 6
Multivariate model of factors associated with the increase in total costs at the pediatric intensive care unit (n = 443; R2 48%).
p  (95% CI)
Constant <0.001 3.554 (3.397; 3.710)
Age  groups 0-2 months
2 months - 1 year 0.003 -0.172 (-0.287; -0.057)
1-5  years 0.003 -0.181 (-0.298; -0.063)
5-12 years 0.001 -0.217 (-0.343; -0.091)
Over 12 years 0.376 -0.067 (-0.215; 0.081)
Bloodstream infection No
Yes <0.001 0.648 (0.499; 0.797)
Pneumonia No
Yes 0.008 0.254 (0.067; 0.442)
Cardiovascular surgery No
Yes <0.001 0.287 (0.196; 0.378)
Type  of admission Medical
Surgical 0.009 -0.149 (-0.260; -0.038)
Immunosuppression No
Yes 0.001 0.199 (0.085; 0.312)
Type  of admission Elective
Urgent 0.004 0.157 (0.050; 0.264)
PRISM  index <0.001 0.014 (0.007; 0.021)
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In this study, we observed a difference of 21 days in PICU
OS between patients with and without NI. Although, the authors
id not adjust by other variables, there was a difference in costs
etween both groups of more than D 30,000. In spite of being statis-
ically signiﬁcant, it may  not be exclusively due to NI. This analysis,
lthough it has been the most frequently used in studies of costs
or NI, has limitations, as it results from an average measure. Also,
t does not reﬂect the real expenditure, considering that this is not
niform throughout the stay, and that, as the NI is time-dependent,
t should measure the extension of the stay only after its diagnosis,
nd not for the entire stay12. Nevertheless, other studies carried
ut in PICU, despite of using a different methodology, and adjusted
ue to other factors like patients’ age or cause of PICU admission,
how similar results, like, Slonim et al.8, who found a difference of
4 days, or Elward et al.9, with a mean hospital LOS cost of D 24,619
n patients with NI.
It also must be taken into account the association between
OS and NI, which may  be contradictory, since, although it is rec-
gnized by the literature that NI increases hospital stay29, some
uthors also consider LOS as a risk factor for the NI30 (longer
ospitalizations leading to colonization of patients by pathogenic
icroorganisms, longer duration of invasive procedures and phar-
acotherapy which favours the development of NI). However, the
ost study presented here was part of a prospective study which
lso analyzed the risk factors associated with NI, not ﬁnding a sig-
iﬁcant association between LOS and NI. Therefore, in this paper,
he authors have assumed that NI has inﬂuenced the increase in
OS, considering what referred by the literature and the results of
he study for risk factors of NI.
Average cost of medical procedures in the current study was
igher in the case of NI patients when compared with non-infected
atients, where the use of antibiotherapy, feeding and imaging tests
hould be highlighted. In the case of bloodstream infection, the cost
f catheters and antibiotics doubled the observed in patients with
neumonia, as in Pittoni and Scatto’s case27, which remarks that
ne of the most difﬁcult challenges is the bloodstream infection
anagement, because of its wide array of possible treatments and
levated associated cost.
Globally, the cost of NI is within the range described in othertudies performed in PICU5,7,9,11,17,31 (from D 1,51017 to D 53,0859).
he last study showed higher costs, which may, in part, be justiﬁed
y the use of a cost-estimation method based upon cost to charge
atios and the inclusion of more complex patients. The BI was themost costly NI, showing signiﬁcant difference when compared to
pneumonia, which it agrees with other studies5,32.
Nevertheless, the results from other studies which only report
average values must be interpreted cautiously. Their costs esti-
mations were obtained in different countries with a healthcare
management which may  not be equivalent to the Spanish Health
System. Likewise, other costs should be considered, such as those
derived from patients who  die as a result of the NI; the cost of
the medical procedures required by the treatment of NI beyond
48 hours after discharge from PICU, or the indirect or intangible
costs referred to productivity loss, and more speciﬁcally what the
patient loses as a result of the infection and/or treatment (pain,
suffering, loss of leisure time), which affects their quality of life.
Some of the variables that were associated with an increase
of total cost (presence of NI, emergency admission, previous car-
diovascular surgery and immunosuppression), were also been
reported by other studies9,16,29. Other factors that may also increase
the cost of the Unit were the cause of non surgical admission and
comorbidities such as severe lesions in primary organs7,9,12,33. In
the present study, only immunosuppression, as a patient’s intrinsic
factor, contributed in a statistically signiﬁcant way to the model. In
this sense, Gemke et al.34 stated that non previously programmed
admissions did increase the use of resources and, consequently,
total costs.
Another factor included in our model as a risk factor is cardio-
vascular surgery, which could be due to the high number of patients
undergoing such surgery in the PICU, postoperative LOS, frequent
infectious complications and prolonged use of medical procedures,
which means an increase of total economic costs. The inclusion of
this factor is supported by a recent report published by González
et al.35, which states that prolonged admissions convey a greater
use of medical resources, higher risk of NI and higher mortality
rates among children admitted to PICU35. Other studies mention
hospital stay1,14 and non survival in the Unit7,9,24 as factors capa-
ble of rising costs. These variables were only statistically signiﬁcant
in the bivariate analysis.
In conclusion, this paper has approached to NI-related economic
cost, where most of the expenses are derived from the medical pro-
cedures made to the patient during PICU stay and its complications.
The higher total cost per patient requires the implementation of
speciﬁc cost-effective preventive measures to control NI, in order
to minimize its effects in the health of pediatric patients and in
medical costs.
Á. Morillo-García et al. / Gac Sa
What is known about the topic?
Nosocomial infection in Pediatric Intensive Care Units has a
signiﬁcant impact on morbidity, mortality and economic cost.
However, very few studies have performed an estimate of the
economic cost of nosocomial infection in public health sys-
tems, since most of them are conﬁned to privately funded
healthcare systems and adult population.
What does this study adds?
The present study provides an estimate of the economic
cost of nosocomial infection in critically ill children, which may
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3be useful to both economic managers and physicians about its
repercussion in economic terms.
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